Semax for Sale USA: Domestic Stock, No Domestic Approval

Semax for sale USA is a logistics claim rather than a status claim, and separating the two is the whole job of this page. Domestic stock means a box leaves a warehouse inside the country and arrives without crossing a border. It does not mean the compound is approved here, manufactured here, tested here, or supervised by anybody here.

Almost all peptide raw material in this market is synthesised abroad, most of it in China, and a US listing usually describes the last leg of the journey rather than the first. A vendor holding stock domestically has imported it, and the substance has already crossed the border in bulk before your order existed. That is not a criticism, it is the shape of the industry, and it means "ships from the USA" and "made in the USA" are separate claims that a listing is free to conflate.

What you are buying is a synthetic heptapeptide: seven residues in the order Met-Glu-His-Phe-Pro-Gly-Pro, the ACTH(4-7) fragment with a Pro-Gly-Pro tail added to slow enzymatic breakdown, registered at PubChem as CID 9811102, formula C37H51N9O10S, molecular weight 813.9. It is not a tuftsin analogue whatever a listing says, because that is Selank, the other Russian heptapeptide and a different molecule.

One supplier is linked here and we earn a commission if you buy through it, which our affiliate disclosure sets out in full. The section on what domestic stock cannot give you has not been softened for that reason.

Four things, and they are real. The first is the border itself. FDA's personal importation guidance is explicit that an unapproved drug offered for import may be refused entry, and its Import Alert 66-41 covers detention without physical examination of unapproved new drugs promoted in the United States, applied to the firms on its published red list. A refused or detained parcel is not a refund, and the loss falls on the buyer. A domestic parcel is never presented for entry, so none of that machinery applies to it.

The second is jurisdiction. A seller with a US business address is reachable by state consumer-protection law and by the courts, which is not the same as being regulated but is not nothing either. An overseas storefront with a contact form is reachable by nobody you can name.

The third is payment recourse. Domestic sellers commonly take cards, and a card leaves a chargeback route with a documented dispute window. Bank transfers and crypto payments, which are far more common on overseas listings, end your recourse the moment they clear. That single difference is worth more than most of what a listing advertises.

The fourth is transit time, which matters for a shipped biological material in a way it does not for a book. Fewer days in transit and no indefinite hold at a port of entry means less time at whatever temperature the parcel happens to be sitting at. Our page on domestic sourcing for MOTS-c works through the same four advantages for a different peptide, and they transfer better than the product names do.

Everything above is about the parcel. None of it is about the substance, and that distinction is where domestic listings do most of their persuading.

There is no FDA oversight of this product, in the United States or anywhere else in the West. There is no approved specification a batch has to be released against, no inspection of the fill, no recall mechanism if a batch turns out to be wrong, and no pharmacy board with jurisdiction, because no pharmacy is involved. Nothing about a domestic address alters any of that.

FDA's own position on the compound, quoted from its page on bulk drug substances that may present significant safety risks: "Compounded drugs containing semax (heptapeptide) may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA has no, or limited, safety-related information for proposed routes of administration. Therefore, the agency lacks sufficient information to know whether the drug would cause harm if administered to humans."

The mechanism it names is a manufacturing one, which is why a batch certificate is worth something here. A published document showing purity against a specification, an endotoxin result and a sterility screen addresses a genuine part of what the agency raised. It does not address the last sentence. No certificate produces human safety data, and a domestic warehouse produces even less of it. Both halves have to stay in view at once.

The reason there is no regulated American version of this product is specific and checkable. A pharmacy compounding under section 503A of the Federal Food, Drug and Cosmetic Act may work from a bulk drug substance only if it meets a United States Pharmacopeia or National Formulary monograph, is a component of an FDA-approved drug product, or appears on FDA's 503A bulks list. Semax clears none of those conditions.

The history behind the third one gets mangled constantly. Semax was nominated for the list, was placed in category 2 under FDA's interim policies while the agency evaluated it, and the nomination was then withdrawn. It sits on no current category list at all. Category 2 today contains six substances, and Semax is not one of them. So a page describing it as a current category 2 substance is repeating a status that ended, and a page calling it banned has invented a term.

For a US buyer the practical effect is the same under either description: nothing lawful to prescribe, nothing lawful to compound, and therefore nothing dispensed by any American pharmacy. That is why every domestic listing you find sells it as research material and why none of them can offer a prescription version, however the site is styled. Compare that with the position on NAD+, where a genuine clinic and compounding channel exists in the United States and the interesting questions are about price and quality rather than about availability.

A domestic claim is worth exactly as much as its evidence, and four things separate a checkable listing from a decorated one.

A stated dispatch origin and a real cut-off. A vendor holding US stock can tell you where it ships from and when it goes out. Vague phrasing about fast worldwide fulfilment, with no domestic address anywhere on the site, usually means a parcel that will be presented at a border.

A published returns and reshipment policy in writing. Read what it actually covers. A policy that excludes opened items and does not mention lost or damaged parcels is a policy that resolves nothing on the only occasions you would need it.

A batch certificate published before purchase, with a lot number you can match. This is the check that makes every other document meaningful. Ascension publishes a four page combined certificate for Semax batch 30-05260628 reporting purity at 99.886 percent against a greater-than-98-percent specification, bacterial endotoxin by kinetic chromogenic LAL to USP Chapter 85 at under 0.20 EU/mL against a 0.5 EU/mL limit, and a rapid microbial sterility screen returning no growth. Its own February certificate for the same compound carries neither of the last two tests, which tells you those tests are a batch decision rather than a product one, and that the certificate to read is every one on the page rather than only the clickable link.

Card payment. If the only routes offered are bank transfer, crypto or a payment app, the seller has removed your one remaining piece of leverage and you should read that as the design decision it is.

The commercial terms on the listing we link, checked on 21 August 2026: $59.99 for a 10 mg lyophilised vial, $30.00 with the code PEPTIDEDECK, which is $3.00 per milligram, with quantity purchases of three, five or ten taking 3, 5 or 10 percent off the list price and free shipping starting at $250. Whether the code and the tiers combine is not documented, so do not plan an order around the assumption that they do.

The listing describes a lyophilised powder in a sealed vial, and the certificate gives the labelled quantity as 10 mg. Two checks on arrival are worth more than everything you read before ordering.

First, match the lot number on the vial against the lot number on the certificate you read. If they do not match, you have documentation for a different batch, and the correct response is to ask for the certificate covering the one you were sent rather than to assume the difference is administrative. Second, follow the storage condition the vendor states on the listing and keep the order confirmation with the batch number, so that the paper trail exists before you need it rather than after.

We give no preparation guidance on this site and none appears here. For the same arrival checks applied to a different compound, our page on Selank sold from US stock covers the neighbouring peptide, and the February-to-June change in what both certificates cover is the most instructive thing either page has to offer. Domestic stock solves the border. The evidence attached to the vial is a separate problem, and it is the one that decides whether the purchase was sound.